The Peptide Report
A generation of high-performing executives has quietly traded IV drips and pills for a faster-absorbing NAD+ nasal spray. Here's why the format change matters — and what the science says.
The afternoon crash isn't a willpower problem—it's a mitochondrial one. Here's why high-performers are quietly trading their 3 PM espresso for a faster, cleaner cellular reset.
